A novel COLD-PCR/FMCA assay enhances the detection of low-abundance IDH1 mutations in gliomas.
about
Novel multiplex bead-based assay for detection of IDH1 and IDH2 mutations in myeloid malignancies.What do we know about IDH1/2 mutations so far, and how do we use it?Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer.An immuno-wall microdevice exhibits rapid and sensitive detection of IDH1-R132H mutation specific to grade II and III gliomasIDH1/2 mutation detection in gliomas.Isocitrate dehydrogenase 1 and 2 mutations in gliomas.
P2860
A novel COLD-PCR/FMCA assay enhances the detection of low-abundance IDH1 mutations in gliomas.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
A novel COLD-PCR/FMCA assay en ...... nce IDH1 mutations in gliomas.
@en
A novel COLD-PCR/FMCA assay en ...... nce IDH1 mutations in gliomas.
@nl
type
label
A novel COLD-PCR/FMCA assay en ...... nce IDH1 mutations in gliomas.
@en
A novel COLD-PCR/FMCA assay en ...... nce IDH1 mutations in gliomas.
@nl
prefLabel
A novel COLD-PCR/FMCA assay en ...... nce IDH1 mutations in gliomas.
@en
A novel COLD-PCR/FMCA assay en ...... nce IDH1 mutations in gliomas.
@nl
P2093
P1476
A novel COLD-PCR/FMCA assay en ...... nce IDH1 mutations in gliomas.
@en
P2093
Brendan Pang
Marina N Nikiforova
Mary B Durso
Ronald L Hamilton
P356
10.1097/PDM.0B013E31826C7FF8
P577
2013-03-01T00:00:00Z